Evidence map›Paper›PMID 29977836›Full record

ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2018

Neutrophil-Lymphocyte Ratio as a Prognostic Factor in Laryngeal Carcinoma.

Beyhan Yılmaz, Engin Şengül, Aylin Gül, Ulaş Alabalık, Fazıl Emre Özkurt, Mehmet Akdağ, İsmail Topçu

Abstract read
In one paragraph

Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Beyhan Yılmaz1Department of ENT, Dicle University School of Medicine, Diyarbakir, 21280 Turkey.
Engin Şengül1Department of ENT, Dicle University School of Medicine, Diyarbakir, 21280 Turkey.
Aylin Gül1Department of ENT, Dicle University School of Medicine, Diyarbakir, 21280 Turkey.
Ulaş Alabalık2Dicle University Medical School Pathology Department, Diyarbakir, Turkey.
Fazıl Emre Özkurt1Department of ENT, Dicle University School of Medicine, Diyarbakir, 21280 Turkey.
Mehmet Akdağ1Department of ENT, Dicle University School of Medicine, Diyarbakir, 21280 Turkey.
İsmail Topçu1Department of ENT, Dicle University School of Medicine, Diyarbakir, 21280 Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim of this study; investigate whether neutrophils/lymphocyte ratio (NLR) could be used as a prognostic factor in larynx cancer. The correlation between preoperative peripheral blood NLR and age, gender, smoking, alcohol use, clinical stage and differentiation degree was examined. One hundered fourty-four patients in Dicle University Department of Otorhinolaryngology between the years of 2005 and 2014 were included in the study. Clinical and preoperative laboratory data of patients were screened retrospectively from archive files of otorhinolaryngology and the pathology results were screened retrospectively from archive files of pathology. The study was approved by the local ethics committee of the department and carried out in accordance with the declaration of Helsinki as amended in 2013. Statistical analyses were performed using the SPSS 15.0 software package for Windows (SPSS inc., Chicago, IL, USA). There was a significant difference between NLR and clinical stage (

Indexed as

Laryngeal cancerNeutrophils lymphocyte ratioPrognostic factor

Identifiers

PMID29977836
PMCPMC6015577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.